MODEL 203 LIFE PULSE HIGH FREQUENCY VENTILATOR
Bunnell, Inc. · Decision date Jun 30, 1988
What did the FDA approve?
FDA records P850064 as an original PMA application. The recorded decision is approval, dated Jun 30, 1988.
An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Anesthesiology
- Decision date
- Jun 30, 1988
Regulatory record facts
- Identifier
- P850064
- Regulatory pathway
- Premarket approval application
- Applicant
- Bunnell, Inc.
- Product code
- LSZ
- Decision code
- APPR
- Decision date
- Jun 30, 1988
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: VENTILATOR, HIGH FREQUENCY.
- Applicant
- Bunnell, Inc.
- Product code
- LSZ
- FDA device class
- 3
FDA decision timeline
P850064 received
Application receipt date recorded by FDA.
P850064 · FDA decision
APPR
P850064/S056 · Related supplement
LifePulse High Frequency Ventilator
Timeline entries are records held by MedtechLedger for P850064. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P850064
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LifePulse High Frequency VentilatorP850064/S056 | Bunnell, Inc. | PMA supplement | Sep 28, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bunnell, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 436 Lawndale Dr., Salt Lake City, UT, 84115
Sources and methodology
- Original FDA record: P850064
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records